Tag Archives: SNH

Top 10 Low Price Stocks To Watch For 2018

The U.S. Commerce Department backed Boeing in its challenge to Bombardier, recommending an enormous tariff on sales of Bombardier’s C Series jetliner, a major blow to the Canadian plane maker.

The initial ruling by the International Trade Commission, an arm of the Commerce Department, recommends a 219.63% tariff on the delivery of each airliner, according to a person briefed on the ITC’s findings.

Boeing (BA), America’s largest exporter and sole U.S. producer of commercial airliners, is suing Bombardier. At issue is whether Bombardier received financial backing from the Canadian government that allowed the plane maker to stay afloat and sell to Delta for what Boeing alleges were “absurdly low prices.”

“The U.S. values its relationships with Canada, but even our closest allies must play by the rules,” said Commerce Secretary Wilbur Ross in a statement. “The subsidization of goods by foreign governments is something that the Trump Administration takes very seriously, and we will continue to evaluate and verify the accuracy of this preliminary determination.”

Top 10 Low Price Stocks To Watch For 2018: Gol Linhas Aereas Inteligentes S.A.(GOL)

Advisors’ Opinion:

  • [By Dan Caplinger]

    Yet some stocks didn’t participate in the rally, instead contending with negative news of their own. Zoe’s Kitchen (NYSE:ZOES), GOL Lineas Aereas Inteligentes (NYSE:GOL), and Sarepta Therapeutics (NASDAQ:SRPT) were among the worst performers on the day. Below, we’ll look more closely at these stocks to tell you why they did so poorly.

  • [By Monica Gerson]

    Gol Linhas Aereas Inteligentes SA (ADR) (NYSE: GOL) is expected to post a quarterly loss at $0.73 per share on revenue of $705.31 million.

    Caretrust REIT Inc (NASDAQ: CTRE) is estimated to post its quarterly earnings at $0.26 per share on revenue of $22.21 million.

  • [By Lisa Levin]

    Regional Airlines: The industry dropped 1.9 percent by 11:00 am. The worst performer in this industry was Gol Linhas Aereas Inteligentes SA (ADR) (NYSE: GOL), which declined 5.8 percent.

Top 10 Low Price Stocks To Watch For 2018: General Growth Properties, Inc.(GGP)

Advisors’ Opinion:

  • [By Paul Ausick]

    GGP Inc. (NYSE: GGP) posted a new 52-week low of $22.12 on Wednesday, down about 2.2% compared with Tuesday’s closing price of $22.61. The stock’s 52-week high is $32.10. Volume of around 4 million shares was about 20% below the daily average of around 5 million shares. The retail REIT had no specific news.

  • [By Paul Ausick]

    Rounding out the top 10 in terms of total installed solar PV capacity are Prologis Inc. (NYSE: PLD) with 108 MWs of installed capacity, Apple Inc.(NASDAQ: AAPL with 94 MWs, Costco Wholesale Corp. (NASDAQ: COST) with 51 MWs, Kohl’s Corp. (NYSE: KSS) with 50 MWs, IKEA with 44 MWs, Macy’s Incl. (NYSE: M) with 39 MWs, General Growth Properties Inc. (NYSE: GGP) with 30 MWs, and tied with 23 MWs, Hartz Mountain and Bed, Bath and Beyond Inc. (NASDAQ: BBBY).

  • [By Paul Ausick]

    GGP Inc. (NYSE: GGP) posted a new 52-week low of $21.05 on Wednesday, down about 8.6% from Tuesday’s closing price of $23.04. The stock’s 52-week high is $31.35. Volume totaled around 17 million shares, well over double the daily average of around 6.5 million. The REIT missed revenue estimates this morning.

  • [By Paul Ausick]

    GGP Inc. (NYSE: GGP) posted a new 52-week low of $21.05 on Monday, down 1.5% compared with Friday’s closing price of $21.37. The stock’s 52-week high is $32.10. Volume of around 13 million shares was more than double the daily average of around 5.3 million shares. The company slipped after announcing earnings this morning but is on a pace to close the day up more than 4.5%.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Tuesday was GGP Inc. (NYSE: GGP) which rose about 17% to $22.21. The stocks 52-week range is $18.83 to $27.10. Volume was about51 million compared to its average volume of 5.7 million.

  • [By Chris Lange]

    The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Monday was GGP Inc. (NYSE: GGP) which jumped about 4.7% to $22.62. The stocks 52-week range is $21.05 to $32.10. Volume was roughly 14.5 million which is above the daily average of around 5.3 million shares.

Top 10 Low Price Stocks To Watch For 2018: Fossil Inc.(FOSL)

Advisors’ Opinion:

  • [By Ben Levisohn]

    After running through their scenarios,Boruchow comes up with five losers from Trump’s tax plans: Carters (CRI), Urban Outfitters (URBN), Under Armour (UA), Fossil Group (FOSL) and Gap (GPS). He explains why:

  • [By Nicholas Rossolillo]

    Wearable devices are quickly becoming mainstream technology, with smartwatches and fitness trackers leading the way. You’d never know that based on the performance of traditional watchmaker Fossil Group (NASDAQ:FOSL) as the company is struggling to adapt to the changing times.

  • [By WWW.THESTREET.COM]

    Fossil is in deep trouble: As mentioned earlier in the week, Fossil (FOSL) came out with more big plans for the smartwatch market at Basel World. Unfortunately, as TheStreet reported, the company is fighting an uphill battle with Apple and could be in big trouble. 

Top 10 Low Price Stocks To Watch For 2018: Daimler AG (DDAIF)

Advisors’ Opinion:

  • [By John Rosevear]

    So without further ado, let’s take a closer look at the three: General Motors (NYSE:GM), Daimler AG (NASDAQOTH:DDAIF), and Delphi Automotive (NYSE:DLPH).

  • [By SEEKINGALPHA.COM]

    Through an alliance and investment in Nissan in 1999 Renault currently holds 43% of Japanese car manufacturer Nissan. Since 1999 Nissan has performed well and currently Nissan is worth $43B. Nissan is attractively valued with a P/E of 6.9 a P/B of 0.92 and P/S of 0.41 and a dividend yield of 4.2%. Renault’s stake of 43% in Nissan is worth ($43*0.43=) $18.5B. This means that the other operations of Renault including its 73.3% stake in leading Russian car manufacturer AutoVaz and 1.55% stake in Daimler are valued at only $8.5B. The market value of AutoVaz is $644M which means Renaults stake is worth approximately $472M. Daimler (OTCPK:DDAIF) is worth $77.4B which leads to a value of 1.2B for the 1.55% piece owned by Renault.

  • [By SEEKINGALPHA.COM]

    Companies like Volvo (OTCPK:VOLVY), General Motors (NYSE:GM), Suzuki (OTCPK:SZKMF), Mercedes (OTCPK:DDAIF), and Ford (NYSE:F) are all using the small Swedish company’s tech. The most prominent use for zForce is in the dashboard infotainment center, but it’s also being used as gesture control for closing the tailgate or opening a door and even in using the steering wheel.

  • [By SEEKINGALPHA.COM]

    Daimler-Mercedes (OTCPK:DDAIF)

    The Wall Street Journal reported that, “Daimler plans to unveil an electric concept car at (next month’s) Paris Auto show. Leaks suggest this will be accompanied by bullish plans to release at least six electric cars”. Of course, Daimler is already quite advanced in EVs with its partnership in China with BYD. As I write this, the Paris Auto show has begun, where “Daimler Mercedes-Benz unveiled a battery-powered sport-utility vehicle, a direct competitor to Tesla’s Model X, which will have a range of 310 miles on a single charge and is slated to launch in 2020. The vehicle will be part of a new sub-brand of Mercedes called EQ”.

  • [By SEEKINGALPHA.COM]

    Other manufacturers are also planning to produce and sell all-electric trucks by the end of the current decade – Reuters reports that Navistar International Corp. (NYSE:NAV) and Volkswagen AG’s (OTCPK:VLKAF) Truck and Bus are working together to launch an electric medium duty truck by late 2019, while rival Daimler AG (OTCPK:DDAIF) has delivered the first of a smaller range of electric trucks to customers in New York. These are designed for shorter ranges than the Tesla semi but will likely see expanded ranges as battery technology advances.

  • [By SEEKINGALPHA.COM]

    Apart from the locals, the global competitors have also made some quick moves to make their presence felt in China. According to Reuters, Volkswagen (OTCPK:VLKAY) has recently signed a preliminary deal to set up a joint venture with China-based Anhui Jianghuai Automobile (JAC) for making electric vehicles. However, the deal has enough hurdles in its path. Also, Daimler (OTCPK:DDAIY) (OTCPK:DDAIF) is also readying some electric cars for China under the Mercedes-Benz brand.

Top 10 Low Price Stocks To Watch For 2018: H&R Block, Inc.(HRB)

Advisors’ Opinion:

  • [By Trey Thoelcke]

    H&R Block Inc.s (NYSE: HRB) latest quarterly earnings report is expected after Tuesday’s close. The consensus estimates call for a net loss of $0.62 in per share and $129.07 million in revenue. Shares closed trading most recently at $29.71, in a 52-week range of $19.85 to $31.80. The consensus price target is $27.67.

  • [By Danny Vena]

    H&R Block, Inc. (NYSE:HRB) is hoping to change all that. This year, it’s partnering with IBM’s (NYSE:IBM) Watson to bring the capabilities of artificial intelligence (AI) to tax return preparation. This would seem a natural fit for theJeopardy!-winning supercomputer.

  • [By Lisa Levin]

    H & R Block Inc (NYSE: HRB) was down, falling around 14 percent to $20.42 as the company reported a disappointing tax season. The company announced plans to lower 13 percent of its workforce. Oppenheimer downgraded H&R Block from Outperform to Perform.

  • [By Ben Levisohn]

    H&R Block (HRB) soared to the top of the S&P 500 today after reporting better than expected earnings and sales.

    Agence France-Presse/Getty Images

    H&R Block gained 15% to $23.95 today, while the S&P 500 fell 0.2% to 2,362.98.

    Barrington Research’s Alexander Paris andChris Howe write that “early tax season results [are] encouraging” for H&R Block. They explain why:

    Managements long-term goal is to grow clients in both the Assisted and DDIY categories. While it will not grow clients in tax season 2017, management expects to significantly reduce client losses. Its approach to tax season 2017 includes changes in all customer facing areas of the business, including its sales and service model, promotion pricing and products (its Refund Advance product, free federal 1040EZ in its offices and free federal 1040EZ/1040A and state filing DDIY offering), and marketing. Through the first half of the tax season, H&R Blocks client volumes have improved and the company is achieving share gains in both the Assisted and DDIY categories. In total, the IRS reported a decline in e-files of 10% through February 24 compared to HRBs decline of 7%. In the Assisted category, HRB outperformed the industry with a decline of 8% compared to the IRS reported decline of 13%. In the DDIY category, HRB outperformed the industry with a decline of 5% compared to the IRS reported decline of 8%. While overall industry and HRB volume is expected to improve in the second half of the tax season, HRBs performance relative to the industry is expected to moderate as its Free Federal 1040EZ and Refund Advance promotions ended February 28.

    H&R Block’s market capitalization rose to $5 billion today from $4.3 billion yesterday.

  • [By Ben Levisohn]

    H&R Block (HRB) has climbed 3.1% to $22.20 after beating earnings forecasts by a penny and hiking its dividend.

    Cliffs Natural Resources (CLF) has gained 1.2% to $5.16 after getting upgraded to Outperform from Market Perform at Macquarie.

  • [By Monica Gerson]

    Shares of H & R Block Inc (NYSE: HRB) surged over 12 percent on Friday as the company reported better-than-expected results for its fourth quarter and lifted its quarterly dividend to $0.22 per share. H & R Block shares gained 0.29 percent to $24.30 in the after-hours trading session.

Top 10 Low Price Stocks To Watch For 2018: Senior Housing Properties Trust(SNH)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Healthcare real estate is just as defensive of an investment as net-lease retail, and has even more growth potential in the years ahead. One beaten-down healthcare REIT that I have my eye on in 2017 is Senior Housing Properties Trust (NASDAQ:SNH).

Top 10 Low Price Stocks To Watch For 2018: Veeva Systems Inc.(VEEV)

Advisors’ Opinion:

  • [By Keith Speights, Brian Stoffel, and George Budwell]

    Healthcare is changing rapidly. Which companies will emerge as the huge winners with these major changes? We asked three of our healthcare contributors to weigh in on the subject. Here’s whyAbbVie (NYSE:ABBV),Alphabet (NASDAQ:GOOGL) (NASDAQ:GOOG), Johnson & Johnson (NYSE:JNJ), and Veeva Systems (NYSE:VEEV) could represent bold bets on the future of healthcare.

  • [By Peter Graham]

    Mid cap global life sciencescloud-based software solutions stock Veeva Systems Inc (NYSE: VEEV) reported fiscal Q1 2018 earnings after the market closed yesterday with earningsbeating expectations. Total revenuesincreased 32% to$157.9 million as subscription services revenues rose 33% to $127.3 million whilenet incomeincreased 57% to $36.0million. The CEO commented:

  • [By Brian Stoffel]

    Last week, management at Veeva Systems (NYSE:VEEV) reported earnings that investors have become accustomed to. In fact, shareholders have been downright spoiled: both the top and bottom lines came in ahead of expectations; annual sales growth from Veeva’s non-CRM division came in at a blistering 113%.

  • [By Brian Stoffel]

    To say that Veeva Systems (NYSE:VEEV) has performed well as a publicly traded company would be an understatement. While the stock itself is actually down since its post-IPO days, the company’s fundamentals have vastly improved during that time frame.

  • [By Jim Robertson]

    Today, our Elite Opportunity Pronewsletter suggested mid cap global life sciencescloud-based software solutions stock Veeva Systems Inc (NYSE: VEEV) as a bullish long trade for investors who have patience:

  • [By Brian Stoffel]

    HR and payroll specialist Paycom Software (NYSE:PAYC), mortgage software provider Ellie Mae (NYSE:ELLI), and cloud computing king for drug companies Veeva Systems (NYSE:VEEV) are the three best software companies you could buy in 2017. They share three key traits that any investor can love: high switching costs, blazing growth rates, and founders or CEOs with lots of skin in the game.

Top 10 Low Price Stocks To Watch For 2018: SodaStream International Ltd.(SODA)

Advisors’ Opinion:

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reported Q1 2017 earnings before the market opened this morning. Revenue increased 14.3% to $115.3 million driven by growth in each of the Company’s four geographic regions, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased 141.8% to $14.7 million.

  • [By Peter Graham]

    The Q4 2016 earnings report for Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) is scheduled for before the market opens onWednesday (February 15). However, theIsrael connection along with changing consumer tastes havesent sharesfrom fizzy to being flat. On the other hand,Sodastream International climbed 16.22% after releasing third quarter earnings that easily topped Wall Street expectations after making efforts to revamp its image.

  • [By Jeremy Bowman]

    SodaStream International(NASDAQ:SODA) blew the market away in 2016 as shares of the DIY soda-maker popped 142%, beating all but two stocks in the S&P 500.

  • [By Peter Graham]

    Israel based small cap home beverage carbonation stockSodastream International Ltd (NASDAQ: SODA) reportedQ2 2017 earnings before the market opened on Wednesday. Revenue increased 9.6% to $130.6 millionwith theincrease driven by growth in most of the Company’s geographic regions -mainly Western Europe, partially offset by a negative foreign currency exchange impact mainly due to the weakening of the Euro/U.S. Dollar exchange rate compared to the same period in 2016. Net income increased approximately 84% to $14.4 million. As of June 30, 2017, the Company had cash and bank deposits totaling $108.5 million compared to $57.3 millionas ofDecember 31, 2016. The CEO commented:

Top 10 Low Price Stocks To Watch For 2018: H&E Equipment Services Inc.(HEES)

Advisors’ Opinion:

  • [By Peter Graham]

    A long term performance chart shows shares of United Rentalsgiving a similar performance and pulling away fromsmall cap peer H&E Equipment Services, Inc (NASDAQ: HEES):

Top 10 Low Price Stocks To Watch For 2018: Natural Gas(NG)

Advisors’ Opinion:

  • [By James E. Brumley]

    When an investor thinks of Canadian gold mining stocks, NovaGold Resources Inc. (USA) (NYSEMKT:NG) and Yamana Gold Inc. (USA) (NYSE:AUY) are often the first names to come to mind. And well they should. Yamana Gold is a $2.5 billion giant, and NovaGold Resources seems to have been around forever.

    Those two icons aren’t the only way to tap into Canada’s sizeable gold mining industry though. There’s a small, up-and-coming player called Taranis Resources Inc. (OTCMKTS:TNREF, TSX:TRO) that could end up becoming another key fixture of the country’s mining landscape.

    Taranis develops mineral deposits into mine-ready projects. Its primary project right now — and it’s enough to keep the company plenty busy for the next several years — is the Thor property located near Trout Lake, British Columbia. NI 43-101 resource reports (indicated and inferred)suggest Thor contains 6.9 million ounces of silver, 35,000 ounces gold, 57 million pounds of lead, 79.4 million pounds of zinc and 3.3 Million pounds of copper (roughly a 14 million ounce silver equivalent (“AgEq”) deposit*) laying in wait in a way that lends itself to the establishment of a low-cost, open pit mining operation. That’s roughly $300 million worth of marketable metals, and the estimates have been steadily getting bigger as Tanaris does more survey work.

    And 2017 could be a real breakout year for Taranis, as a lot of the work that’s been done to date starts to mean something. It’s got big exploration plans for this year… this spring/summer to be exact.

    The Phase 1 program was completed in September of last year, setting the stage for a more defined and much bigger Phase 2 definition-drilling within the next several weeks. This Phase 2 definition drilling slated for the middle of this year will drill down to between 6000 m and 10,000 m.

    These so-called first generation target areas are generally well understood areas based on sound geological information includ

  • [By William Romov]

    Over the last year, the number of short positions on gold stocks has fallen. One of these stocks is a Canadian gold mining company called NovaGold Resources Inc. (NYSE: NG). In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400. This shows a shift in sentiment from bearish to bullish for gold.

  • [By Money Morning Staff Reports]

    Canadian gold mining company NovaGold Resources Inc. (NYSE: NG) shows an even starker change in sentiment. In the last 12 months, the volume of short bets on the stock declined 79%, to 522,400.

9 Small-Cap Stocks to Buy for 2018

When was the last time that small-cap stocks outperformed the S&P 500 Index? Take a guess? Any guess? It wasn’t as long ago as you might think. The answer is 2016.

According to Morningstar, the iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) had an annual total return of 22% last year, almost double the 12% total return of the SPDR S&P 500 ETF Trust (NYSEARCA:SPY).

So far this year, the SPY is beating the proxy for small-cap stocks by almost 800 basis points. Over the past decade, however, IWM bested SPY on six occasions, suggesting good things do come in small packages.

Should the Trump tax plan get passed, small-cap stocks should benefit significantly from the fact they generate a significant portion of their revenue domestically where they’ll be taxed at 20% instead of the old rate of 35%.

Large-cap stocks might have gotten an edge up in 2017, but the coming year is looking good for smaller companies. Here are my nine small-cap stocks to own in 2018.

Small-Cap Stocks to Buy in 2018: RMR Group (RMR) investorplace.com/wp-content/uploads/2017/05/rmrmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

RMR Group Inc (NASDAQ:RMR) is an alternative asset manager based in Newton, Massachusetts, that primarily handles the day-to-day operations of four REITs: Hospitality Properties Trust (NASDAQ:HPT), Senior Housing Properties Trust (NASDAQ:SNH), Select Income REIT (NASDAQ:SIR) and Government Properties Income Trust (NASDAQ:GOV).

These four REITs have no employees and are managed by RMR. No matter what happens to REITs due to higher interest rates, etc., short of bankruptcy, RMR gets paid to manage $28 billion of commercial real estate assets.

In April 2016, I called GOV one of the five best REITs to own that broke the mold by being unconventional. In the case of GOV, it was owning and managing government office space. At the time of my article, it owned 10.7 million square feet of office space over 71 properties with 93% of the space rented to government agencies.

As a result of its October 2017 acquisition of First Potomac Realty Trust, GOV now owns 24.9 million square feet of office space.

Also, it owns 28% of SIR, one of the other REITs managed by RMR. It’s a little incestuous, I’ll grant you, but it’s a great way to separate fee-generating revenue from income-generating revenue.

Small-Cap Stocks to Buy in 2018: Callaway Golf (ELY) Callaway Golf Co (NYSE:ELY)investorplace.com/wp-content/uploads/2017/03/elymsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/03/elymsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/03/elymsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/03/elymsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/03/elymsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/03/elymsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/03/elymsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/03/elymsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/03/elymsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/03/elymsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Call me crazy, but I believe golf is ready for a mini-comeback given the NFL appears to be slowly imploding due to multiple factors including an ownership base that seems oblivious to the fact Roger Goodell is highly overpaid.

It might be hard to believe, but Callaway Golf Co (NYSE:ELY) is finishing off a third consecutive year with ELY stock in positive territory for the year, up 32% year to date through Dec. 11. The company’s been making under-the-radar acquisitions in 2017 that will position it for future growth.

In January, it paid $76 million for Ogio International Inc., a golf-bag manufacturer. Then in August, it acquired TravisMathew, a high-end lifestyle apparel brand that it can extend beyond the golf course, for $126 million.

At the end of October, Callaway announced healthy third-quarter 2017 results that included much stronger profits and revenue growth across all segments and regions.

I see a fourth consecutive year of strong returns for ELY stock.

Small-Cap Stocks to Buy in 2018: Fox Factory (FOXF) investorplace.com/wp-content/uploads/2017/06/foxfmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/06/foxfmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Whether you’re a motocross rider or someone who just enjoys offroading with your ATV, the shocks you put on your vehicle can make all the difference in the comfort and quality of your ride.

Fox Factory Holding Corp. (NASDAQ:FOXF) has been manufacturing shock absorbers for powered and non-powered vehicles since 1974. FOXF went public in August 2013 at $15 a share.

FOXF stock started off slowly after its IPO, never getting more than two or three dollars above $15 until July 2016 when investors started to take notice. Since then, it’s more than doubled in price and is up 43% year to date through Dec. 11.

On Dec. 1, Fox Factory announced that it was buying 80% of the Tuscany Motor Company for $53.4 million and the option to acquire the remaining 20% in the future. While Tuscany only adds $41 million in revenue, it gives the company a new platform on which to expand its aftermarket business.

If you want a dressed up F-150 truck, Tuscany can help you out.

Small-Cap Stocks to Buy in 2018: Buckle (BKE)

investorplace.com/wp-content/uploads/2016/12/bkemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/12/bkemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/12/bkemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/12/bkemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/12/bkemsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2016/12/bkemsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2016/12/bkemsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/12/bkemsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/12/bkemsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/12/bkemsn-170×93.jpg170w” sizes=”(max-width: 728px) 100vw, 728px” />

There are stock recommendations and then there are gut feels. Putting Buckle Inc (NYSE:BKE) on this list of small-cap stocks, it fits under the latter category.

I was once a big believer in its stock recommending it as recently as January 2016. However, in that article, I did admit it wasn’t performing too well and would require a patient investor to ride out the downturn. Somewhere along the way, Buckle fell out of favor with shoppers, and its financial situation went from great to just good.

On Dec. 5, Buckle announced it would pay a $1.75 special cash dividend to shareholders of record as of Jan. 12, 2018, in addition to the regular 25-cent dividend. That’s $7.47 in special cash dividends the company’s paid out over the past five years. Of course, considering its stock is down 5% annually over the same period, it only cushions the blow.

With comps still in negative territory but margins improving, I’m going to go out on a limb here and say 2018 is the year this small-cap stock delivers the goods.

Small-Cap Stocks to Buy in 2018: Viad (VVI) investorplace.com/wp-content/uploads/2017/01/vvimsn-1-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/01/vvimsn-1-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

In September, I recommended Viad Corp (NYSE:VVI) as one of two stocks to buy whose market cap was lower than GoPro Inc (NASDAQ:GPRO). Since then, VVI is down 2% versus a 24% decline for GPRO.

While VVI has yet to come to life, I have reason to believe 2018 will be a good year for its stock.

First, in November, Viad’s travel experience business announced that it would expand its FlyOver virtual flight concept that began with FlyOver Canada by acquiring 55% of Iceland’s Esja Attractions. Iceland continues to be one of the world’s greatest tourism destinations; this new attraction will drive further growth in its Pursuit segment.

Secondly, acquisitions its GES exhibition business made in 2017, have yet to deliver upon the synergies and cost savings originally expected. However, CEO Steve Moster did say in the Q3 2017 earnings release that the addition of higher-margin services to its offerings is driving top- and bottom-line profits.

VVI stock has done well the past six years with not a single year of declines. With all that it’s doing to grow the travel side of its business, I see that streak continuing in 2018.

Small-Cap Stocks to Buy in 2018: PetMed Express (PETS)

investorplace.com/wp-content/uploads/2017/12/petsmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/12/petsmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/12/petsmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/12/petsmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/12/petsmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/12/petsmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/12/petsmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/12/petsmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/12/petsmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/12/petsmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />

It seems that controversy seems to follow PetMed Express Inc (NASDAQ:PETS), America’s largest pet pharmacy.

In the summer, PETS faced troubling allegations from short sellers that it was marketing painkillers meant for animals to humans. Its stock tanked down to the mid-$30s before recovering in the fall on strong earnings.

This isn’t the first time the company’s faced controversy. In the past, it’s had a rocky relationship with the veterinary community who believe PetMed Express is trying to undermine their businesses through lower prices and misleading advertising.

I don’t think PETS will ever escape the focus of investors because once you’re targeted as a good short, you can never scare them away except by delivering strong results as it did in Q2 2017.

Historically, PETS has delivered strong returns, and as long as it continues to boost the order value per customer — $85 in Q2 2017, $3 more than a year earlier — I don’t see why it can’t produce another year of appreciation.

Small-Cap Stocks to Buy in 2018: iRobot (IRBT) investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

iRobot Corporation (NASDAQ:IRBT) owns an impressive 64% of the global robotic vacuum cleaner market. Recently, I saw an ad for the Shark ION ROBOT vacuum, an indication that although the competition is mounting, it also legitimizes the entire robotic vacuum industry.

I can remember when investors were hypercritical of iRobot because it wasn’t expanding its business further into the military arena. You want to talk about competitive, just try getting a contract with the federal government. It takes deep pockets and even deeper patience.

In May, I called IRBT on of the best growth stocks to buy, in part because it had fully recovered from its troubles stemming from its defense-related business which it dumped in 2016. The fact is, iRobot’s become a fan of short sellers, and that’s made its stock seriously volatile. And that’s a good thing when it comes to small-cap stocks.

In July, IRBT stock was trading over $105; today, it’s around $70. I believe it will continue to grow its main product at a reasonable pace while it figures out the next great thing to diversify its revenue streams.

In the meantime, you might want to continue to buy on weakness. In 2018, given its strong robotic patents, iRobot could be a good acquisition candidate.

Small-Cap Stocks to Buy in 2018: WisdomTree Investments (WETF)

WisdomTreeinvestorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />

Don’t look now but WisdomTree Investments, Inc. (NASDAQ:WETF) is shaking up upper management.

Probably the biggest news from the organizational changes WETF is making is that board member Jarrett Lilien is stepping down to join day-to-day operations as Executive Vice President in charge of Emerging Technologies. Lilien was COO of E*Trade Financial Corp (NASDAQ:ETFC) between 2003 and 2008.

The ETF asset manager is probably best known for its WisdomTree Japan Hedged Equity Fund (NYSEARCA:DXJ) which is the second-largest Japan-focused ETF in the U.S. with $9.5 billion in assets.

Although DXJ is its highest-profile ETF, it has 12 ETFs with more than $1 billion in assets and considerably more with $100 million or more, making it the seventh-largest ETF provider in the U.S.

While it’s had a tough time grabbing market share in the Canadian ETF market, which it entered in July 2016, its partnership with Canadian online broker Questrade should help make a dent. The company’s aware that it needs to go global and the organizational changes are meant to address this need.

I see its stock above $20 by the end of 2018, 2019 at the latest.

Small-Cap Stocks to Buy in 2018: Oxford Industries (OXM) investorplace.com/wp-content/uploads/2017/12/oxmmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

The apparel manufacturer and retailer’s bounced back nicely after a down year in 2016.

Oxford Industries Inc (NYSE:OXM) owns a trio of apparel brands: Tommy Bahama, Lily Pulitzer and Southern Tide, which it acquired in April 2016 for $85 million.

If you’re not familiar with Southern Tide, it has a nice big fish as its logo, doing its best to keep up with polo players and crocodiles.

On Dec. 5, OXM announced its Q3 2017 results and they were solid. Furthermore, it expects fiscal 2017 earnings on an adjusted basis to be as high as $3.38 a share on $1.1 billion in sales.

Highlights in 2017 include Lily Pulitzer delivering solid operating margins through the first nine months — 22.7% versus 6.6% for Tommy Bahama, its biggest brand by sales — and its latest acquisition becoming profitable on the year.

With the help of Southern Tide growth over the next 2-3 years, I could see OXM stock hitting $100 in 2018.

As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities.

Compare Brokers

9 Small-Cap Stocks to Buy for 2018

When was the last time that small-cap stocks outperformed the S&P 500 Index? Take a guess? Any guess? It wasn’t as long ago as you might think. The answer is 2016.

According to Morningstar, the iShares Russell 2000 Index (ETF) (NYSEARCA:IWM) had an annual total return of 22% last year, almost double the 12% total return of the SPDR S&P 500 ETF Trust (NYSEARCA:SPY).

So far this year, the SPY is beating the proxy for small-cap stocks by almost 800 basis points. Over the past decade, however, IWM bested SPY on six occasions, suggesting good things do come in small packages.

Should the Trump tax plan get passed, small-cap stocks should benefit significantly from the fact they generate a significant portion of their revenue domestically where they’ll be taxed at 20% instead of the old rate of 35%.

Large-cap stocks might have gotten an edge up in 2017, but the coming year is looking good for smaller companies. Here are my nine small-cap stocks to own in 2018.

Small-Cap Stocks to Buy in 2018: RMR Group (RMR) investorplace.com/wp-content/uploads/2017/05/rmrmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/05/rmrmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

RMR Group Inc (NASDAQ:RMR) is an alternative asset manager based in Newton, Massachusetts, that primarily handles the day-to-day operations of four REITs: Hospitality Properties Trust (NASDAQ:HPT), Senior Housing Properties Trust (NASDAQ:SNH), Select Income REIT (NASDAQ:SIR) and Government Properties Income Trust (NASDAQ:GOV).

These four REITs have no employees and are managed by RMR. No matter what happens to REITs due to higher interest rates, etc., short of bankruptcy, RMR gets paid to manage $28 billion of commercial real estate assets.

In April 2016, I called GOV one of the five best REITs to own that broke the mold by being unconventional. In the case of GOV, it was owning and managing government office space. At the time of my article, it owned 10.7 million square feet of office space over 71 properties with 93% of the space rented to government agencies.

As a result of its October 2017 acquisition of First Potomac Realty Trust, GOV now owns 24.9 million square feet of office space.

Also, it owns 28% of SIR, one of the other REITs managed by RMR. It’s a little incestuous, I’ll grant you, but it’s a great way to separate fee-generating revenue from income-generating revenue.

Small-Cap Stocks to Buy in 2018: Callaway Golf (ELY) Callaway Golf Co (NYSE:ELY)investorplace.com/wp-content/uploads/2017/03/elymsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/03/elymsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/03/elymsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/03/elymsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/03/elymsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/03/elymsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/03/elymsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/03/elymsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/03/elymsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/03/elymsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Call me crazy, but I believe golf is ready for a mini-comeback given the NFL appears to be slowly imploding due to multiple factors including an ownership base that seems oblivious to the fact Roger Goodell is highly overpaid.

It might be hard to believe, but Callaway Golf Co (NYSE:ELY) is finishing off a third consecutive year with ELY stock in positive territory for the year, up 32% year to date through Dec. 11. The company’s been making under-the-radar acquisitions in 2017 that will position it for future growth.

In January, it paid $76 million for Ogio International Inc., a golf-bag manufacturer. Then in August, it acquired TravisMathew, a high-end lifestyle apparel brand that it can extend beyond the golf course, for $126 million.

At the end of October, Callaway announced healthy third-quarter 2017 results that included much stronger profits and revenue growth across all segments and regions.

I see a fourth consecutive year of strong returns for ELY stock.

Small-Cap Stocks to Buy in 2018: Fox Factory (FOXF) investorplace.com/wp-content/uploads/2017/06/foxfmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/06/foxfmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/06/foxfmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

Whether you’re a motocross rider or someone who just enjoys offroading with your ATV, the shocks you put on your vehicle can make all the difference in the comfort and quality of your ride.

Fox Factory Holding Corp. (NASDAQ:FOXF) has been manufacturing shock absorbers for powered and non-powered vehicles since 1974. FOXF went public in August 2013 at $15 a share.

FOXF stock started off slowly after its IPO, never getting more than two or three dollars above $15 until July 2016 when investors started to take notice. Since then, it’s more than doubled in price and is up 43% year to date through Dec. 11.

On Dec. 1, Fox Factory announced that it was buying 80% of the Tuscany Motor Company for $53.4 million and the option to acquire the remaining 20% in the future. While Tuscany only adds $41 million in revenue, it gives the company a new platform on which to expand its aftermarket business.

If you want a dressed up F-150 truck, Tuscany can help you out.

Small-Cap Stocks to Buy in 2018: Buckle (BKE)

investorplace.com/wp-content/uploads/2016/12/bkemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2016/12/bkemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2016/12/bkemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2016/12/bkemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2016/12/bkemsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2016/12/bkemsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2016/12/bkemsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2016/12/bkemsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2016/12/bkemsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2016/12/bkemsn-170×93.jpg170w” sizes=”(max-width: 728px) 100vw, 728px” />

There are stock recommendations and then there are gut feels. Putting Buckle Inc (NYSE:BKE) on this list of small-cap stocks, it fits under the latter category.

I was once a big believer in its stock recommending it as recently as January 2016. However, in that article, I did admit it wasn’t performing too well and would require a patient investor to ride out the downturn. Somewhere along the way, Buckle fell out of favor with shoppers, and its financial situation went from great to just good.

On Dec. 5, Buckle announced it would pay a $1.75 special cash dividend to shareholders of record as of Jan. 12, 2018, in addition to the regular 25-cent dividend. That’s $7.47 in special cash dividends the company’s paid out over the past five years. Of course, considering its stock is down 5% annually over the same period, it only cushions the blow.

With comps still in negative territory but margins improving, I’m going to go out on a limb here and say 2018 is the year this small-cap stock delivers the goods.

Small-Cap Stocks to Buy in 2018: Viad (VVI) investorplace.com/wp-content/uploads/2017/01/vvimsn-1-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/01/vvimsn-1-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/01/vvimsn-1-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

In September, I recommended Viad Corp (NYSE:VVI) as one of two stocks to buy whose market cap was lower than GoPro Inc (NASDAQ:GPRO). Since then, VVI is down 2% versus a 24% decline for GPRO.

While VVI has yet to come to life, I have reason to believe 2018 will be a good year for its stock.

First, in November, Viad’s travel experience business announced that it would expand its FlyOver virtual flight concept that began with FlyOver Canada by acquiring 55% of Iceland’s Esja Attractions. Iceland continues to be one of the world’s greatest tourism destinations; this new attraction will drive further growth in its Pursuit segment.

Secondly, acquisitions its GES exhibition business made in 2017, have yet to deliver upon the synergies and cost savings originally expected. However, CEO Steve Moster did say in the Q3 2017 earnings release that the addition of higher-margin services to its offerings is driving top- and bottom-line profits.

VVI stock has done well the past six years with not a single year of declines. With all that it’s doing to grow the travel side of its business, I see that streak continuing in 2018.

Small-Cap Stocks to Buy in 2018: PetMed Express (PETS)

investorplace.com/wp-content/uploads/2017/12/petsmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/12/petsmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/12/petsmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/12/petsmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/12/petsmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/12/petsmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/12/petsmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/12/petsmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/12/petsmsn-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/12/petsmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />

It seems that controversy seems to follow PetMed Express Inc (NASDAQ:PETS), America’s largest pet pharmacy.

In the summer, PETS faced troubling allegations from short sellers that it was marketing painkillers meant for animals to humans. Its stock tanked down to the mid-$30s before recovering in the fall on strong earnings.

This isn’t the first time the company’s faced controversy. In the past, it’s had a rocky relationship with the veterinary community who believe PetMed Express is trying to undermine their businesses through lower prices and misleading advertising.

I don’t think PETS will ever escape the focus of investors because once you’re targeted as a good short, you can never scare them away except by delivering strong results as it did in Q2 2017.

Historically, PETS has delivered strong returns, and as long as it continues to boost the order value per customer — $85 in Q2 2017, $3 more than a year earlier — I don’t see why it can’t produce another year of appreciation.

Small-Cap Stocks to Buy in 2018: iRobot (IRBT) investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-78×43.jpg 78w,https://investorplace.com/wp-content/uploads/2017/05/irbtmsn-1-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

iRobot Corporation (NASDAQ:IRBT) owns an impressive 64% of the global robotic vacuum cleaner market. Recently, I saw an ad for the Shark ION ROBOT vacuum, an indication that although the competition is mounting, it also legitimizes the entire robotic vacuum industry.

I can remember when investors were hypercritical of iRobot because it wasn’t expanding its business further into the military arena. You want to talk about competitive, just try getting a contract with the federal government. It takes deep pockets and even deeper patience.

In May, I called IRBT on of the best growth stocks to buy, in part because it had fully recovered from its troubles stemming from its defense-related business which it dumped in 2016. The fact is, iRobot’s become a fan of short sellers, and that’s made its stock seriously volatile. And that’s a good thing when it comes to small-cap stocks.

In July, IRBT stock was trading over $105; today, it’s around $70. I believe it will continue to grow its main product at a reasonable pace while it figures out the next great thing to diversify its revenue streams.

In the meantime, you might want to continue to buy on weakness. In 2018, given its strong robotic patents, iRobot could be a good acquisition candidate.

Small-Cap Stocks to Buy in 2018: WisdomTree Investments (WETF)

WisdomTreeinvestorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-91×50.jpg 91w,https://investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/04/wisdomtreemsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />

Don’t look now but WisdomTree Investments, Inc. (NASDAQ:WETF) is shaking up upper management.

Probably the biggest news from the organizational changes WETF is making is that board member Jarrett Lilien is stepping down to join day-to-day operations as Executive Vice President in charge of Emerging Technologies. Lilien was COO of E*Trade Financial Corp (NASDAQ:ETFC) between 2003 and 2008.

The ETF asset manager is probably best known for its WisdomTree Japan Hedged Equity Fund (NYSEARCA:DXJ) which is the second-largest Japan-focused ETF in the U.S. with $9.5 billion in assets.

Although DXJ is its highest-profile ETF, it has 12 ETFs with more than $1 billion in assets and considerably more with $100 million or more, making it the seventh-largest ETF provider in the U.S.

While it’s had a tough time grabbing market share in the Canadian ETF market, which it entered in July 2016, its partnership with Canadian online broker Questrade should help make a dent. The company’s aware that it needs to go global and the organizational changes are meant to address this need.

I see its stock above $20 by the end of 2018, 2019 at the latest.

Small-Cap Stocks to Buy in 2018: Oxford Industries (OXM) investorplace.com/wp-content/uploads/2017/12/oxmmsn-300×165.jpg 300w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-55×30.jpg 55w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-200×110.jpg 200w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-162×88.jpg 162w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-400×220.jpg 400w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-116×64.jpg 116w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-100×55.jpg 100w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-91×50.jpg 91w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-78×43.jpg 78w, investorplace.com/wp-content/uploads/2017/12/oxmmsn-170×93.jpg 170w” sizes=”(max-width: 728px) 100vw, 728px” />Source: Shutterstock

The apparel manufacturer and retailer’s bounced back nicely after a down year in 2016.

Oxford Industries Inc (NYSE:OXM) owns a trio of apparel brands: Tommy Bahama, Lily Pulitzer and Southern Tide, which it acquired in April 2016 for $85 million.

If you’re not familiar with Southern Tide, it has a nice big fish as its logo, doing its best to keep up with polo players and crocodiles.

On Dec. 5, OXM announced its Q3 2017 results and they were solid. Furthermore, it expects fiscal 2017 earnings on an adjusted basis to be as high as $3.38 a share on $1.1 billion in sales.

Highlights in 2017 include Lily Pulitzer delivering solid operating margins through the first nine months — 22.7% versus 6.6% for Tommy Bahama, its biggest brand by sales — and its latest acquisition becoming profitable on the year.

With the help of Southern Tide growth over the next 2-3 years, I could see OXM stock hitting $100 in 2018.

As of this writing, Will Ashworth did not hold a position in any of the aforementioned securities.

Compare Brokers

stock trading forum

Yesterday’s upbeat report on consumer spending and income in the US provides fresh support for last week’s moderately hawkish comments from Fed officials, who hinted that another interest rate hike is near, perhaps as early as next month’s Federal Open Market Committee (FOMC) meeting. Yet, support for pricing in a new round of policy tightening is modest at best via Treasury yields. Is that because job growth is expected to slow in this Friday’s employment report for July after two months of strong increases?

Total nonfarm payrolls are on track to rise by a moderate 175,000 in August, according to Econoday.com’s consensus forecast. That’s a decent gain, but it’s well below July’s increase of 255,000 and July’s 292,000 surge. Monthly data is noisy, and so it’s best to focus on the year-over-year trend. The August estimate translates into a 1.74% increase versus the year-earlier level, fractionally above July’s annual pace.

Job growth has clearly slowed in year-over-year terms, which isn’t terribly surprising for an economic recovery that’s celebrated its seventh birthday in June – one of the longest expansions on record, according to NBER data. The question is whether the Fed will feel compelled to continue squeezing rates when the trend for job growth is on a downward trajectory.

stock trading forum: Regeneron Pharmaceuticals, Inc.(REGN)

Advisors’ Opinion:

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) tumbled to the bottom of the S&P 500 today after a judge said the company could be forced to stop selling an anti-cholesterol drug due to violating an Amgen (AMGN) patent.

    Agence France-Presse/Getty Images

    Regeneron Pharmaceuticalsdropped 5.8% to $358.68 today, while the S&P 500 rose 0.4% to 2,276.98.

    Chardan’sGbola Amusa takes a victory lap:

    Yesterday, after markets closed, it was announced that US Federal District Court Judge Sue Robinson ruled to issue a permanent injunction against Praluent, the PCSK9 mAb for hypercholesterolemia from partners Regeneron and Sanofi, due to infringement of patents from Amgen. The court has imposed a 30-day suspension (stay) on the injunction to allow for settlement or appeal of the District Court decision. Sanofi and Regeneron have announced their intent to appeal the ruling to the US Court of Appeals for the Federal Circuit (CAFC). The injunction decision is consistent with our counter-consensus published views communicated on 25 January 2016 (“Downgrade to Sell on evidence of likely infringement of Amgen’s PCSK9 patents”) and subsequently. Based on consultation with expert legal counsel, we now put >75% probability Amgen will prevail on appeal and/or Praluent is ultimately removed from the US market, and/or Amgen achieves a settlement substantially in its favor. We currently model $3.3 bn in non-risk-adjusted 2022E US revenues for Praluent, while consensus models $1.2 bn in 2022E US revenues. We reiterate our view from 25 January 2016 to preferentially own Amgen, The Medicines Company (MDCO) (Buy), and Alnylam (ALNY) (Buy) over Regeneron for exposure to PCSK9 inhibitor market dynamics as outcomes trials approach.

    While the loss is bad news for Regeneron, Barron’s Johanna Bennettargues that it could herald a comeback for Amgen.

    Regeneron’s market capitalization fell to $38.5 billion today from $40.2 bil

  • [By Todd Campbell, Demitrios Kalogeropoulos, and Reuben Gregg Brewer]

    In the case of these three stocks, however, it may be worth taking a gamble. Our contributors think catalysts at Regeneron Pharmaceuticals (NASDAQ:REGN), Royal Dutch Shell (NYSE:RDS-B), and United Parcel Service (NYSE:UPS) can get them back to their winning ways. Read on to find out if these down-and-out stocks are right for your portfolio.

  • [By Ben Levisohn]

    Regeneron Pharmaceuticals (REGN) soared to the top of the S&P 500 today after a competitor’s competing drug failed a Phase 3 trial.

    Getty Images

    Regenerongained 3.8% to $387.10 today, while the S&P 500 declined 0.1% to 2,256.96.

    RBC’s Adnan Butt and Michael Yee offer their take:

    Two Phase 3 studies comparing Ophthotechs (OPHT) Fovista plus Lucentis to Lucentis alone did not meet the primary endpoint of demonstrating a better vision for the combination at 12 months. The improvements were 10.24 letters for the combo vs. 10.01 for Lucentis when the two Phase 3s were combined. Individually, one Phase 3 showed combo improvement of 10.74 letters vs. 9.82 letters alone and the second 9.91 letters vs. 10.36 letters with Lucentis alone. A third Phase 3 study combining Fovista with Eylea or Avastin is ongoing…

    Big overhang removed; [Regeneron] shares should be up and then continue to rise with the focus moving to dupilumab. Overhang was that Fovista success and approval could disrupt the market for Eylea as more docs tried combining nearly free Avastin (off-label) with Fovista to improve outcomes with patients. We had always argued that even under that scenario Eylea would be used since it is the most potent agent. We are buyers at current level especially ahead of the upcoming dupilumab launch.

    Regeneron’s market capitalization rose to $51.5 billion today from $39.3 billion yesterday. It reported net income of $636 million on sales of $4.1 billion in 2015.

  • [By Chris Lange]

    Shares of Amgen Inc. (NASDAQ: AMGN) saw a handy gain to close out the week after the company won a Delaware court ruling that blocked Sanofi (NYSE: SNY) and Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) from selling their cholesterol-lowering drug in the United States. Essentially the court found that the drug Praluent actually infringed upon Amgens patents for its rival treatment Repatha.

  • [By Johanna Bennett]

    Shares of biotechnology giant Regeneron Pharmaceuticals (REGN) have climbed more than 4% today after Piper Jaffray analyst Ed Tenthoff upgraded the stock from a neutral to an overweight, with a $446 price target.

    The upgrade comes just a few days after the drug maker released soft guidance for 2017 and forecasts called for slowing sales of the eye drug Eylea.

    But Piper Jaffrays Tenthoff argues that anticipated approvals and deep pipeline should drive long-term value. Of particular importance: the atopic dermatitis drug Dupixent (dupilumab).

    We are confident in FDA approval of Dupixent (dupilumab) in moderate-to-severe atopic dermatitis by the March 29th PDUFA date and in Europe in late 2017. The Phase III LIBERTY ASTHMA QUEST study has fully enrolled 1,858 persistent asthma patients to 200mg and 300mg subcu Dupixent q2W. We look for data this year to enable an sBLA submission by YE:17. Regeneron is conducting two Phase III trials in nasal polyps and will initiate Phase III pediatric atopic dermatitis and asthma trials. The company will report data from a Phase II eosinophilic esophagitis study in 1H:17 and begin a Phase II food allergy study in 2H:17. The FDA has deemed Sanofi’s Le Trait facility “acceptable”. As a result, we anticipate the partners will refile on Kevzara (sarilumab) and could gain approval in 2Q:17. These two launches should turn Regeneron’s antibody alliance with Sanofi profitable.

    Todays news is the latest development in what has been a volatile time the drug maker. The shares have fallen sharply over the during the last three months, the result of a patent suit with Amgen (AMGN) over its anti-cholesterol drug Praluent, which a judge had set it wouldnt be able to sell in the U.S. , But last week, a judge granted a stay that would allow Regeneron to sell Praluent. It also fueled a pop in its shares.

    The next day, however, Regeneron reported earnings, and while profits o

stock trading forum: Platform Specialty Products Corporation(PAH)

Advisors’ Opinion:

  • [By WWW.THESTREET.COM]

    In his second “Executive Decision” segment, Cramer spoke with Rakesh Sachdev, CEO of Platform Specialty Products (PAH) , the agriculture and industrial roll-up company which has seen its shares double over the past 12 months. Yesterday, Platform Specialty delivered a two-cents-a-share earnings beat.

  • [By Lee Jackson]

    Platform Specialty Products Corp. (NYSE: PAH) had a well-known seller parting with a huge chunk of stock. Bill Ackman’s Pershing Square hedge fund sold a total of 2,285,888 shares of the stock at $8.78 apiece. The total for the sale was posted at $20 million.The company produces and sells specialty chemical products in the Americas, the Asia-Pacific and Europe. The stock closed last Friday at $8.52.

stock trading forum: Senior Housing Properties Trust(SNH)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Healthcare real estate is just as defensive of an investment as net-lease retail, and has even more growth potential in the years ahead. One beaten-down healthcare REIT that I have my eye on in 2017 is Senior Housing Properties Trust (NASDAQ:SNH).

stock trading forum: Siebert Financial Corp.(SIEB)

Advisors’ Opinion:

  • [By Jim Robertson]

    On Tuesday, our Under the Radar Moversnewsletter suggested shorting small cap discount brokerageSiebert Financial Corp (NASDAQ: SIEB):

    Siebert Financial has been on our watchlist for a while, overbought and toying with the idea of a pullback. We’re finally starting to see evidence that the weight of the gain is taking a toll. We’ve seen a string of lower highs following the last bullish gasp from the 9th. We’re going to assume that was the pivot point. (It has been so far, anyway.)

  • [By Lisa Levin]

    Siebert Financial Corp. (NASDAQ: SIEB) shares shot up 61 percent to $8.30 following news it will offer deeply discounted online trading of U.S. equities next year.

  • [By Cameron Saucier]

    Siebert (Nasdaq: SIEB) is a holding company that has a retail discount brokerage business through its subsidiary, Muriel Siebert & Co. SIEB rose 60% last month after it announced a purchasing agreement with Kennedy Cabot Acquisition. Under the agreement, Kennedy Cabot will purchase shares of SIEB. SIEB is currently trading at $3.37 per share and is up 157% YOY.

stock trading forum: MannKind Corporation(MNKD)

Advisors’ Opinion:

  • [By WWW.MONEYSHOW.COM]

    MannKind Corp. (MNKD) has developed a drug, Afrezza, which is a new form of inhalable insulin that is proving to have many benefits over existing mealtime insulins for diabetics.  

  • [By James E. Brumley]

    When most investors think of diabetes stocks, names like Novo Nordisk A/S (ADR) (NYSE:NVO) and MannKind Corporation (NASDAQ:MNKD) come to mind. And well they should. Novo Nordisk is the biggest insulin company in the world, and while MannKind is relatively small, it’s a name that turns heads simply because it came up with an inhalable insulin that – after a slow start – is getting a little traction.

    In both cases though, the paradigm is the same one that was first used decades ago. That is, if a person isn’t making their own insulin, then it must be introduced externally. What if instead a diabetic’s glucose levels could be controlled by turning on the cells in their body responsible for processing that sugar? That’s the approach Cell MedX Corp (OTCMKTS:CMXC) is taking, using a relatively new but very compelling science.

    While chemical-based manufactured pharmaceuticals were largely the core of healthcare for well over the past century, it’s become clear that our bodies – right down to our cells – are also electrical in nature. Not only do they produce it, they need it to function properly. The FDA has even recently approved a therapeutic device that delivers mild electrical currents to and through an individual’s body as a means of treating pain. This “electromedicine” has also shown a certain degree of efficacy as a treatment for several illnesses, including cancer. Specifically, electrical currents have been demonstrated to force pleomorphic cancer microbes into hibernation, essentially making a cancerous cell a normal, healthy cell again. So, using an electrical current as a means of therapy for diabetics isn’t far-fetched at all. Indeed, it’s quite brilliant.

    As for how Cell MedX is using the idea, it’s actually quite simple. The device is called an eBalance. At first glance it just looks like another ordinary tablet computer. A closer inspection of the e-Balance device, however, makes it clear that it’s not just another tablet. It’

  • [By Peter Graham]

    The Q4 2016 earnings report for troubled small cap diabetes stock MannKind Corporation (NASDAQ: MNKD) is scheduled for after the market closes Thursday (March 16th). So far,MannKind Corporations novel rapid-acting inhaled insulin therapy Afrezza has been a disappointment for investors; and if that doesnt start to change, theMNKD could soon run out of money. For that reason, the Company has elevated short interest of 36.43% according to Highshortinterest.com.

  • [By Sean Williams]

    Last summer, my mind was fully set on short-selling shares (i.e., betting they go down) of drugmaker MannKind (NASDAQ:MNKD). My investment thesis was pretty straightforward: MannKind was eventually going to seek bankruptcy protection.

stock quotes today

9 Ways to Save on Taxes in Retirement

If Trump Wants to Kill DOL Rule, Hed Better Act Soon

The Roth Annuity: A Bright Star in Annuity Investing

Baird says it has added three advisors in New Jersey and Florida from Wells Fargo Advisors with close to $390 million in client assets.

The employee-owned wealth management firm, which is based in Milwaukee, says the three veteran reps have joined its Private Wealth Management group in Morristown, N.J., and West Palm Beach, Fla. Both locations are new office sites for Baird.

RBG, which operates as an RIA, has 15 affiliate offices nationwide.

Also moving to RBG is Asa Kajihiro of Honolulu. Kajihiro has 12 years of experience and was previously with Edward Jones.

Meanwhile, LPL Financial attracts affiliated advisors from rival IBDs, as RBC hires a longtime Merrill advisor with long career at…

You are signed up!

ThinkAdvisor’s TechCenter is an educational resource designed to give you a competitive edge by keeping you abreast of new tech innovations and need-to-know information that can be applied to your business. Resources Outlook 2017: Capitalizing on Change

Read our outlook to help find opportunities amid uncertainty in 2017. Our market strategists offer views on the economy and the stock and bond markets….

stock quotes today: B Communications Ltd.(BCOM)

Advisors’ Opinion:

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares fell by 0.77 percent. Meanwhile, top losers in the sector included United States Cellular Corp (NYSE: USM), down 5 percent, and B Communications Ltd (NASDAQ: BCOM), down 5 percent.

  • [By Lisa Levin]

    In trading on Monday, telecommunications services shares rose by just 0.2 percent. Meanwhile, top losers in the sector included B Communications Ltd (NASDAQ: BCOM), down 4 percent, and Partner Communications Company Ltd (ADR) (NASDAQ: PTNR), down 2 percent.

stock quotes today: Senior Housing Properties Trust(SNH)

Advisors’ Opinion:

  • [By Matthew Frankel]

    Healthcare real estate is just as defensive of an investment as net-lease retail, and has even more growth potential in the years ahead. One beaten-down healthcare REIT that I have my eye on in 2017 is Senior Housing Properties Trust (NASDAQ:SNH).

stock quotes today: Navidea Biopharmaceuticals, Inc.(NAVB)

Advisors’ Opinion:

  • [By Monica Gerson]

    Navidea Biopharmaceuticals Inc (NYSE: NAVB) shares rose 8.80 percent to $0.950 in pre-market trading as the company reported an unsolicited offer to refinance CRG loan.

stock quotes today: Pacira Pharmaceuticals, Inc.(PCRX)

Advisors’ Opinion:

  • [By Lisa Levin]

    Pacira Pharmaceuticals Inc (NASDAQ: PCRX) shares were also up, gaining 17 percent to $39.80. Pacira Pharmaceuticals reported preliminary 2016 revenue of $276.4 million.

  • [By Chris Lange]

    Pacira Pharmaceuticals Inc. (NASDAQ: PCRX) has announced preliminary unaudited total revenues and net product sales for Exparel for the fourth quarter and the full year. Total revenues were $72.9 million and $276.4 million for the fourth quarter and full year, respectively. Exparel net product sales were $71.4 million and $239.9 million for the same periods, respectively. The consensus estimates from Thomson Reuters were calling for revenues of $72.56 million in the fourth quarter and $276.09 million in the full year.